Skip to content
← Back to this collection

PUBLICATIONS · 35952322

Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JCO Precis Oncol
Publication date
2022 Aug
First author
Ogura K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Ogura K
      type
      Author
    2. name
      Elkrief A
      type
      Author
    3. name
      Bowman AS
      type
      Author
    4. name
      Koche RP
      type
      Author
    5. name
      de Stanchina E
      type
      Author
    6. name
      Benayed R
      type
      Author
    7. name
      Mauguen A
      type
      Author
    8. name
      Mattar MS
      type
      Author
    9. name
      Khodos I
      type
      Author
    10. name
      Meyers PA
      type
      Author
    11. name
      Healey JH
      type
      Author
    12. name
      Tap WD
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Ogura K
      type
      Author
    2. name
      Elkrief A
      type
      Author
    3. name
      Bowman AS
      type
      Author
    4. name
      Koche RP
      type
      Author
    5. name
      de Stanchina E
      type
      Author
    6. name
      Benayed R
      type
      Author
    7. name
      Mauguen A
      type
      Author
    8. name
      Mattar MS
      type
      Author
    9. name
      Khodos I
      type
      Author
    10. name
      Meyers PA
      type
      Author
    11. name
      Healey JH
      type
      Author
    12. name
      Tap WD
      type
      Author
    bibliography ids
    1. nci-bib-8dc775c56b79df61e8f74495
    book metadata
    content sha256
    91dfd34ef32dd5a7900546546301317752299eb300bc1d180405d37b2ca5a55b
    document type
    citation
    dois
    1. 10.1200/PO.22.00048
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35952322
    immutable id
    pubmed:35952322@91dfd34ef32dd5a7900546546301317752299eb300bc1d180405d37b2ca5a55b
    journal
    abbreviation
    JCO Precis Oncol
    issn electronic
    2473-4284
    issn print
    Source null
    issue
    Source null
    name
    JCO precision oncology
    nlm unique id
    101705370
    pages
    e2200048
    volume
    6
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35952322
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      c739765184746ef8885962188f552bce865c5254f4c0bb8c7e5877adc80bdc1e
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Aug
      precision
      month
      year
      2022
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35952322/
      title
      Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance.

      Preserved source evidence · Independent clinical review pending · Not medical advice